Use the Back button in your browser to see the other results of your search or to select another record.
| Comparison of noninvasive positive pressure ventilation with standard medical therapy in hypercapnic acute respiratory failure |
| Celikel T, Sungur M, Ceyhan B, Karakurt S |
| Chest 1998 Dec;114(6):1636-1642 |
| clinical trial |
| 6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
STUDY OBJECTIVE: To compare the efficacy of standard medical therapy (ST) and noninvasive mechanical ventilation additional to standard medical therapy in hypercapnic acute respiratory failure (HARF). DESIGN: Single center, prospective, randomized, controlled study. SETTING: Pulmonary medicine directed critical care unit in a university hospital. PATIENTS: Between March 1993 and November 1996, 30 HARF patients were randomized to receive ST or noninvasive positive pressure ventilation (NPPV) in addition to ST. INTERVENTIONS: NPPV was given with an air-cushioned face via a mechanical ventilator (Puritan Bennett 7200) with initial setting of 5 cmH2O continuous positive airway pressure and 15 cmH2O pressure support. RESULTS: At the time of randomization, patients in the ST group had (mean +/- SD) PaO2 of 54 +/- 13 mmHg, PaCO2 of 67 +/- 11 mmHg, pH of 7.28 +/- 0.02, and respiratory rate of 35.0 +/- 5.8 breaths/min. Patients in the NPPV group had PaO2 of 55 +/- 14, PaCO2 of 69 +/- 15, pH of 7.27 +/- 0.07, and respiratory rate of 34.0 +/- 8.1 breaths/min. With ST, there was significant improvement of only respiratory rate (p < 0.05). However, with NPPV, PaO2 (p < 0.001), PaCO2 (p < 0.001), pH (p < 0.001), and respiratory rate (p < 0.001) improved significantly compared with baseline. Six hours after randomization, pH (p < 0.01) and respiratory rate (p < 0.01) in NPPV patients were significantly better than with ST. Hospital stay for NPPV versus ST patients was, respectively, 11.7 +/- 3.5 and 14.6 +/- 4.7 days (p < 0.05). One patient in the NPPV group required invasive mechanical ventilation. The conditions of six patients in the ST group deteriorated and they were switched to NPPV; this was successful in four patients, two failures were invasively ventilated. CONCLUSION: This study suggests that early application of NPPV in HARF patients facilitates improvement, decreases need for invasive mechanical ventilation, and decreases the duration of hospitalization.
|